APA (7th ed.) Citation

Alhalabi, O., Gouda, M. A., Milton, D. R., Momin, H. A., Yilmaz, B., Stephen, B., . . . Tannir, N. M. (2025). A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma. Cancer Medicine, 14(4), 1. https://doi.org/10.1002/cam4.70280

Chicago Style (17th ed.) Citation

Alhalabi, Omar, et al. "A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma." Cancer Medicine 14, no. 4 (2025): 1. https://doi.org/10.1002/cam4.70280.

MLA (9th ed.) Citation

Alhalabi, Omar, et al. "A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma." Cancer Medicine, vol. 14, no. 4, 2025, p. 1, https://doi.org/10.1002/cam4.70280.